• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨膜衔接蛋白 PAG 是 PD-1 抑制性信号在人 T 细胞中的中介。

Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells.

机构信息

Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA.

Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.

出版信息

Commun Biol. 2021 Jun 3;4(1):672. doi: 10.1038/s42003-021-02225-8.

DOI:10.1038/s42003-021-02225-8
PMID:34083754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8175585/
Abstract

The inhibitory receptor PD-1 is expressed on T cells to inhibit select functions when ligated. The complete signaling mechanism downstream of PD-1 has yet to be uncovered. Here, we discovered phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG) is phosphorylated following PD-1 ligation and associate this with inhibitory T cell function. Clinical cohort analysis correlates low PAG expression with increased survival from numerous tumor types. PAG knockdown in T cells prevents PD-1-mediated inhibition of cytokine secretion, cell adhesion, CD69 expression, and ERK phosphorylation, and enhances phosphorylation of SRC following PD-1 ligation. PAG overexpression rescues these effects. In vivo, PAG contributes greatly to the growth of two murine tumors, MC38 and B16, and limits T cell presence within the tumor. Moreover, PAG deletion sensitizes tumors to PD-1 blockade. Here PAG is established as a critical mediator of PD-1 signaling and as a potential target to enhance T cell activation in tumors.

摘要

抑制性受体 PD-1 在与配体结合时表达于 T 细胞上,以抑制特定功能。PD-1 下游的完整信号机制尚未被揭示。在这里,我们发现与富含神经酰胺的糖脂富集微区的磷酸化蛋白 1(PAG)在 PD-1 结合后发生磷酸化,并将其与抑制性 T 细胞功能相关联。临床队列分析表明,PAG 低表达与多种肿瘤类型的生存率提高相关。T 细胞中 PAG 的敲低可阻止 PD-1 介导的细胞因子分泌、细胞黏附、CD69 表达和 ERK 磷酸化的抑制,并增强 PD-1 结合后的 SRC 磷酸化。PAG 的过表达可挽救这些效应。在体内,PAG 极大地促进了 MC38 和 B16 两种鼠肿瘤的生长,并限制了肿瘤内 T 细胞的存在。此外,PAG 的缺失使肿瘤对 PD-1 阻断更为敏感。在这里,PAG 被确立为 PD-1 信号的关键介质,并可能成为增强肿瘤中 T 细胞激活的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/b2f4a17813a6/42003_2021_2225_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/388ac83c0e49/42003_2021_2225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/07ac7c9b5935/42003_2021_2225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/552f54c06e73/42003_2021_2225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/7dc1b56751ad/42003_2021_2225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/cd44385934a1/42003_2021_2225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/53f6c89e3614/42003_2021_2225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/c763792af3a0/42003_2021_2225_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/b2f4a17813a6/42003_2021_2225_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/388ac83c0e49/42003_2021_2225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/07ac7c9b5935/42003_2021_2225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/552f54c06e73/42003_2021_2225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/7dc1b56751ad/42003_2021_2225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/cd44385934a1/42003_2021_2225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/53f6c89e3614/42003_2021_2225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/c763792af3a0/42003_2021_2225_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec97/8175585/b2f4a17813a6/42003_2021_2225_Fig8_HTML.jpg

相似文献

1
Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells.跨膜衔接蛋白 PAG 是 PD-1 抑制性信号在人 T 细胞中的中介。
Commun Biol. 2021 Jun 3;4(1):672. doi: 10.1038/s42003-021-02225-8.
2
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.与富含糖鞘脂微结构域相关的磷蛋白(PAG)是一种新的普遍表达的跨膜衔接蛋白,它与蛋白酪氨酸激酶csk结合并参与T细胞活化的调节。
J Exp Med. 2000 May 1;191(9):1591-604. doi: 10.1084/jem.191.9.1591.
3
Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor.PAG/Cbp对T细胞活化的磷酸化依赖性调控,PAG/Cbp是一种脂筏相关的跨膜衔接蛋白。
Mol Cell Biol. 2003 Mar;23(6):2017-28. doi: 10.1128/MCB.23.6.2017-2028.2003.
4
Reactive glia promote development of CD103 CD69 CD8 T-cells through programmed cell death-ligand 1 (PD-L1).反应性神经胶质通过程序性细胞死亡配体 1(PD-L1)促进 CD103 CD69 CD8 T 细胞的发育。
Immun Inflamm Dis. 2018 Jun;6(2):332-344. doi: 10.1002/iid3.221. Epub 2018 Mar 30.
5
A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration.移位的PAG增强近端信号传导和SDF-1诱导的T细胞迁移。
Eur J Immunol. 2008 Jan;38(1):250-9. doi: 10.1002/eji.200636664.
6
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.人类 Merkel 细胞癌中的肿瘤特异性 T 细胞:Tregs 和 T 细胞耗竭在降低 T 细胞反应中的可能作用。
J Invest Dermatol. 2013 Jul;133(7):1879-89. doi: 10.1038/jid.2013.75. Epub 2013 Feb 18.
7
Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.C 端Src 激酶(CSK)在 FcεRI 介导的肥大细胞激活中的正调控和负调控作用,独立于跨膜衔接蛋白 PAG/CSK 结合蛋白。
Front Immunol. 2018 Aug 2;9:1771. doi: 10.3389/fimmu.2018.01771. eCollection 2018.
8
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth.单克隆抗体对衔接蛋白PAG的中和作用可限制小鼠肿瘤生长。
Mol Ther Methods Clin Dev. 2022 Nov 9;27:380-390. doi: 10.1016/j.omtm.2022.10.012. eCollection 2022 Dec 8.
9
Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.利用原代T细胞的定量蛋白质组学分析重新审视PAG衔接蛋白的作用时机
J Immunol. 2015 Dec 1;195(11):5472-81. doi: 10.4049/jimmunol.1501300. Epub 2015 Oct 28.
10
The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.与磷酸酶PTPN22和Dok衔接蛋白协同作用的Csk相关衔接蛋白PAG抑制效应T细胞活化。
Cell Rep. 2016 Dec 6;17(10):2776-2788. doi: 10.1016/j.celrep.2016.11.035.

引用本文的文献

1
miR-143-3p Promotes T Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1.微小RNA-143-3p通过抑制ABL2和PAG1促进T细胞分化并抑制T细胞的进行性分化。
Genes (Basel). 2025 Apr 19;16(4):466. doi: 10.3390/genes16040466.
2
Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event.Lck的功能与调节:免疫细胞毒性反应及肿瘤治疗——远非简单事件
Cancers (Basel). 2024 Jul 24;16(15):2630. doi: 10.3390/cancers16152630.
3
Exclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell function.

本文引用的文献

1
Pancancer survival analysis of cancer hallmark genes.泛癌生存分析癌症标志基因。
Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5.
2
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions.定量磷酸化蛋白质组学分析揭示PD-1参与多种T细胞功能。
J Biol Chem. 2020 Dec 25;295(52):18036-18050. doi: 10.1074/jbc.RA120.014745. Epub 2020 Oct 19.
3
Molecular mechanism of SHP2 activation by PD-1 stimulation.PD-1 刺激激活 SHP2 的分子机制。
将程序性死亡蛋白1(PD-1)排除在免疫突触之外:一种调节T细胞功能的新策略。
Mol Ther Oncol. 2024 Jun 17;32(3):200839. doi: 10.1016/j.omton.2024.200839. eCollection 2024 Sep 19.
4
Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions.改变细胞表面蛋白质的位置是调节 T 细胞功能的一种很有前途的策略。
Immunology. 2024 Oct;173(2):248-257. doi: 10.1111/imm.13828. Epub 2024 Jul 1.
5
The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling.CD6 相互作用组协调配体非依赖性 T 细胞抑制信号。
Cell Commun Signal. 2024 May 24;22(1):286. doi: 10.1186/s12964-024-01658-y.
6
Batf3 DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy.Batf3 DCs 和 4-1BB/4-1BBL 轴在肿瘤微环境中的效应阶段对于 PD-1/PD-L1 阻断疗效是必需的。
Cell Rep. 2024 May 28;43(5):114141. doi: 10.1016/j.celrep.2024.114141. Epub 2024 Apr 23.
7
A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation.激酶与接头蛋白的故事:Lck、ZAP-70和LAT在调控T细胞发育与激活的开关面板中的作用
Biology (Basel). 2023 Aug 24;12(9):1163. doi: 10.3390/biology12091163.
8
Discovering immunoreceptor coupling and organization motifs.发现免疫受体偶联和组织基序。
Front Immunol. 2023 Sep 4;14:1253412. doi: 10.3389/fimmu.2023.1253412. eCollection 2023.
9
A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy.一种新型肝癌特异性 mTORC1 相关特征,可预测预后和免疫治疗效果。
Aging (Albany NY). 2023 Aug 16;15(16):7933-7955. doi: 10.18632/aging.204862.
10
Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity.长链非编码RNA作为癌症免疫中免疫检查点的表观遗传调控因子
Cancers (Basel). 2022 Dec 28;15(1):184. doi: 10.3390/cancers15010184.
Sci Adv. 2020 Jan 31;6(5):eaay4458. doi: 10.1126/sciadv.aay4458. eCollection 2020 Jan.
4
The Gene Ontology Resource: 20 years and still GOing strong.《基因本体论资源:20 年,持续强大》
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338. doi: 10.1093/nar/gky1055.
5
Proximity Ligation Assay (PLA).邻近连接分析(PLA)。
Curr Protoc Immunol. 2018 Nov;123(1):e58. doi: 10.1002/cpim.58. Epub 2018 Sep 20.
6
Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo.Shp-2 在体内建立 T 细胞耗竭和 PD-1 信号传导方面是可有可无的。
Cell Rep. 2018 Apr 3;23(1):39-49. doi: 10.1016/j.celrep.2018.03.026.
7
Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials.抗PD1/PD-L1单克隆抗体治疗晚期实体瘤的缓解率分析:一项随机临床试验的荟萃分析
Oncotarget. 2018 Jan 20;9(9):8706-8715. doi: 10.18632/oncotarget.24283. eCollection 2018 Feb 2.
8
Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor.PD-1 亲和纯化质谱分析揭示 SAP 作为一种新的检查点抑制剂。
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E468-E477. doi: 10.1073/pnas.1710437115. Epub 2017 Dec 27.
9
Tumor Mutational Burden and Response Rate to PD-1 Inhibition.肿瘤突变负荷与对PD-1抑制的反应率
N Engl J Med. 2017 Dec 21;377(25):2500-2501. doi: 10.1056/NEJMc1713444.
10
Whole-genome landscapes of major melanoma subtypes.主要黑色素瘤亚型的全基因组图谱。
Nature. 2017 May 11;545(7653):175-180. doi: 10.1038/nature22071. Epub 2017 May 3.